Skip to content

    NEOGENOMICS (NEO) stock price & financials

    View NEO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+154.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $164.50M
    $17
    $172.00M
    $34
    $181.33M
    +10.2%
    $13
    -21.2%
    $190.17M
    +10.6%
    $16
    -52.4%
    Weakening
    Operating Profit
    -$21.94M
    $1
    -$18.40M
    -$0
    -$47.63M
    -117.1%
    $0
    -88.6%
    -$13.41M
    +27.1%
    $0
    Weakening
    Net Profit
    -$18.64M
    $1
    -$15.32M
    -$0
    -$45.09M
    -141.9%
    $0
    -92.8%
    -$9.88M
    +35.5%
    $0
    Weakening
    EPS
    $0.75
    $-0.25
    $0.04
    -94.7%
    $0.09
    Weakening
    Other Income
    $0
    $0
    $0
    $0
    -45.5%
    Weakening
    Interest
    $1.67M
    $0
    $1.62M
    $0
    $933.0K
    -44.0%
    $0
    $599.0K
    -63.1%
    $0
    Weakening
    Depreciation
    $0
    $0
    $0
    -38.1%
    $0
    +85.7%
    Strengthening
    Profit before Tax
    -$19.02M
    $1
    -$16.13M
    -$0
    -$45.82M
    -140.9%
    $0
    -93.7%
    -$12.41M
    +23.1%
    $0
    Weakening
    MarginsOPM
    -13.3%
    7.9%
    -10.7%
    -1.3%
    -26.3%
    -96.9%
    1.1%
    -85.6%
    -7.0%
    +34.1%
    2.1%
    Weakening
    Tax
    2.0%
    25.2%
    5.0%
    5.0%
    1.6%
    -19.8%
    28.6%
    +13.2%
    20.4%
    +307.8%
    46.1%
    +823.0%
    Strengthening
    ReturnsROIC
    -73917525.8%
    3.3%
    -60761300.6%
    -1.7%
    -178794607.5%
    -141.9%
    0.2%
    -92.8%
    -39179222.8%
    +35.5%
    0.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$9.81M$173.02M$228.71M$316.83M$263.18M$342.49M$367.01M$159.62M$146.14M
    Short-Term Investments$4
    Total Current Assets$103.67M$290.74M$448.73M$681.51M$605.29M$596.81M$596.02M$376.29M$373.68M
    Net PP&E$60.89M$90.68M$131.66M$211.66M$198.61M$183.78M$173.69M$163.28M$76.70M
    Goodwill$197.89M$198.60M$211.08M$527.12M$522.77M$522.77M$522.77M$524.34M$524.00M
    Intangibles$140.03M$126.64M$120.65M$442.32M$408.26M$373.13M$339.68M$286.53M$278.89M
    Total Assets$505.01M$709.51M$988.33M$1.87B$1.74B$1.68B$1.64B$1.36B$31
    LiabilitiesTotal Current Liabilities$60.92M$63.90M$73.18M$87.23M$89.93M$96.30M$301.24M$88.30M$84.59M
    Short-Term Debt$7.87M$5.00M$0$200.78M$0
    Long-Term Debt$92.88M$538.20M$340.33M$341.86M
    Long-Term Leases$24.03M$42.30M$72.29M$68.95M$67.87M$60.84M$62.82M$61.46M
    Total Liabilities$184.57M$202.10M$294.04M$761.50M$742.01M$739.69M$735.70M$523.27M$31
    EquityCommon Stock & APIC$17
    Retained Earnings-$19.36M-$11.36M-$7.18M-$14.84M-$159.09M-$247.06M-$325.78M-$433.81M$12
    Total Equity$320.44M$507.41M$694.29M$1.11B$998.02M$941.54M$902.34M$836.56M$828.76M
    HighlightsNet Cash / (Debt)-$90.94M-$174.10M-$182.24M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$44.79M$23.37M$1.46M-$26.72M-$65.99M-$1.95M$7.02M$5.23M$30.56M
    Cash from Investing-$139.69M-$19.63M-$159.44M-$632.37M$517.0K$76.71M$12.86M-$12.34M-$15.90M
    Cash from Financing$91.96M$159.47M$235.60M$725.28M$11.83M$4.55M$4.65M-$200.29M-$201.24M
    SummaryCapital Expenditure-$14.31M-$20.03M-$29.10M-$64.14M-$30.89M-$28.75M-$41.06M-$27.01M-$27.51M
    Free Cash Flow$30.48M$3.34M-$27.64M-$90.86M-$96.88M-$30.70M-$34.04M-$21.78M$8.05M
    FCF Margin11.0%0.8%-6.2%-18.8%-19.0%-5.2%-5.2%-3.0%2.2%

    Ratios